IRIS Accounts Production v24.3.2.46 09552237 director 1.5.23 30.4.24 30.4.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh095522372023-04-30095522372024-04-30095522372023-05-012024-04-30095522372022-04-30095522372022-05-012023-04-30095522372023-04-3009552237ns15:EnglandWales2023-05-012024-04-3009552237ns14:PoundSterling2023-05-012024-04-3009552237ns10:Director12023-05-012024-04-3009552237ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3009552237ns10:SmallEntities2023-05-012024-04-3009552237ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3009552237ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3009552237ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3009552237ns10:FullAccounts2023-05-012024-04-3009552237ns10:OrdinaryShareClass12023-05-012024-04-3009552237ns10:RegisteredOffice2023-05-012024-04-3009552237ns5:CurrentFinancialInstruments2024-04-3009552237ns5:CurrentFinancialInstruments2023-04-3009552237ns5:ShareCapital2024-04-3009552237ns5:ShareCapital2023-04-3009552237ns5:RetainedEarningsAccumulatedLosses2024-04-3009552237ns5:RetainedEarningsAccumulatedLosses2023-04-3009552237ns5:ComputerEquipment2023-05-012024-04-3009552237ns5:ComputerEquipment2023-04-3009552237ns5:ComputerEquipment2024-04-3009552237ns5:ComputerEquipment2023-04-3009552237ns10:OrdinaryShareClass12024-04-30095522371ns10:Director12023-04-30095522371ns10:Director12022-04-30095522371ns10:Director12023-05-012024-04-30095522371ns10:Director12022-05-012023-04-30095522371ns10:Director12024-04-30095522371ns10:Director12023-04-30
REGISTERED NUMBER: 09552237 (England and Wales)














Unaudited Financial Statements

for the Year Ended 30 April 2024

for

MAGNUM OPUS MEDICAL SOLUTIONS LIMITED

MAGNUM OPUS MEDICAL SOLUTIONS LIMITED (REGISTERED NUMBER: 09552237)

Contents of the Financial Statements
for the year ended 30 April 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


MAGNUM OPUS MEDICAL SOLUTIONS LIMITED

Company Information
for the year ended 30 April 2024







Director: Miss P Bharucha





Registered office: New Derwent House
69-73 Theobalds Road
London
WC1X 8TA





Registered number: 09552237 (England and Wales)





Accountants: Cooper Parry Advisory Limited
New Derwent House
69-73 Theobalds Road
London
WC1X 8TA

MAGNUM OPUS MEDICAL SOLUTIONS LIMITED (REGISTERED NUMBER: 09552237)

Balance Sheet
30 April 2024

2024 2023
Notes £    £    £    £   
Fixed assets
Tangible assets 4 1,727 1,727

Current assets
Cash at bank 1,683 1,683

Creditors
Amounts falling due within one year 5 3,338 3,338
Net current liabilities (1,655 ) (1,655 )
Total assets less current liabilities 72 72

Capital and reserves
Called up share capital 6 1 1
Retained earnings 71 71
Shareholders' funds 72 72

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 22 January 2025 and were signed by:





Miss P Bharucha - Director


MAGNUM OPUS MEDICAL SOLUTIONS LIMITED (REGISTERED NUMBER: 09552237)

Notes to the Financial Statements
for the year ended 30 April 2024


1. Statutory information

Magnum Opus Medical Solutions Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 20% on reducing balance

Financial instruments
Financial assets and financial liabilities are recognised in the balance sheet when the company becomes a party to the contractual provisions of the instrument.

Trade and other debtors and creditors are classified as basic financial instruments and measured at initial recognition at transaction price. Debtors and creditors are subsequently measured at amortised cost using the effective interest rate method. A provision is established when there is objective evidence that the company will not be able to collect all amounts due.

Cash and cash equivalents are classified as basic financial instruments and comprise cash in hand and at bank and bank overdrafts.

Financial liabilities and equity instruments issued by the company are classified in accordance with the substance of the contractual arrangements entered into and the definitions of a financial liability and an equity instrument. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs.

3. Employees and directors

The average number of employees during the year was 1 (2023 - 1 ) .

4. Tangible fixed assets
Computer
equipment
£   
Cost
At 1 May 2023
and 30 April 2024 2,159
Depreciation
At 1 May 2023
and 30 April 2024 432
Net book value
At 30 April 2024 1,727
At 30 April 2023 1,727

MAGNUM OPUS MEDICAL SOLUTIONS LIMITED (REGISTERED NUMBER: 09552237)

Notes to the Financial Statements - continued
for the year ended 30 April 2024


5. Creditors: amounts falling due within one year
2024 2023
£    £   
Trade creditors 690 690
Taxation and social security 251 251
Other creditors 2,397 2,397
3,338 3,338

6. Called up share capital

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
1 Ordinary £1 1 1

7. Director's advances, credits and guarantees

The following advances and credits to a director subsisted during the years ended 30 April 2024 and 30 April 2023:

2024 2023
£    £   
Miss P Bharucha
Balance outstanding at start of year - (1,434 )
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - -